“…[35][36][37] Possibly these criteria can be extended in the future, depending on more experience based on the stage of the disease, macrovascular invasion, histopathological characteristics (histopathology, aneuploidy, microvascular invasion) as well as DNA and RNA chip data (molecular signature, proteomic signature, and others). 38,39 Clinically, it is most important to shorten the waiting time for transplantation to !6 months. This is difficult to achieve with cadaveric liver transplantation given the shortage of donors.…”